Conferences
ESMO 2023: LITESPARK-013 Phase 2- Safety and Efficacy of Two Doses of Belzutifan in Patients with Advanced Renal Cell Carcinoma (RCC)
October 21, 2023
ESMO 2023: Combination Treatment with Radium-223 and Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer in the REASSURE Study
October 21, 2023
ESMO 2023: STELLAR-304: A Randomized Phase 3 Study of Zanzalintinib (XL092) and Nivolumab in Non-Clear Cell Renal Cell Carcinoma
October 21, 2023
ESMO 2023: LITESPARK-003 Phase 2 Study of Belzutifan in Combination With Cabozantinib for Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
October 21, 2023